It is proposed that the future maturation of PCVs will require a coordinated process across five interconnected dimensions: advances in neoantigen prediction technologies, rapid delivery of PCVs to patients, an increase in anticancer efficacy through combination therapy strategies, establishment of cost-effective manufacturing processes, and regulatory innovation.
Seongje Cho, Jisun Lee, Young-Min Lee et al.· Experimental and Molecular M...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.